Depression screening increased from 40.5 percent in 2017 to 88.8 percent in 2019; increases in screening seen in all at-risk groups
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
FRIDAY, Aug. 19, 2022 (HealthDay News) -- Depression screening increased after implementation of a general screening program in 2017, according to a study published online Aug. 18 in JAMA Network Open.
Maria E. Garcia, M.D., M.P.H., from the University of California in San Francisco, and colleagues examined depression screening rates among populations at risk for undertreatment of depression in a cohort study of electronic record data from 52,944 adults at six primary care facilities from Sept. 1, 2017, to Dec. 31, 2019. Depression screening rates were assessed after implementation of a general screening policy.
The researchers observed an increase in depression screening from 40.5 percent at rollout in 2017 to 88.8 percent in 2019. The likelihood of being screened decreased with increasing age in 2018 (adjusted odds ratios, 0.89 and 0.75 for ages 45 to 54 years and 75 years and older versus 18 to 30 years, respectively). Patients with limited English proficiency, except for Spanish-speaking patients, were less likely to be screened for depression than English-speaking White patients (adjusted odds ratios, 0.59 and 0.55 for Chinese language preference and other non-English preference, respectively). Depression screening had increased for all at-risk groups by 2019, and disparities had disappeared for most; lower odds of screening were still seen for men versus women (adjusted odds ratio, 0.87).
"Given well-documented depression care disparities for men, racial and ethnic minority individuals, patients with language barriers, older patients, and patients with public insurance, a focus on implementing depression screening and initial depression treatment in primary care may help to improve depression recognition and appropriate treatment for all patients," the authors write.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on September 21, 2022
Read this Next
Other Trending Articles